/C O R R E C T I O N -- Cardiac Science Inc./ In the news release, China Health Authority Grants Cardiac Science (NASDAQ:DFIB) Approval to Sell Its Latest Line of Powerheart(R) AEDs, issued earlier today by Cardiac Science Inc. over PR Newswire, we are advised by the company that the third paragraph, last sentence, should read "More than 100 of earlier generation Powerheart CRMs are currently in use in Chinese hospitals," rather than "More than 100 Powerheart CRMs are currently in use in Chinese hospitals," as originally issued inadvertently. PRNewswire -- June 28 DATASOURCE: Cardiac Science, Inc. Web site: http://www.cardiacscience.com/

Copyright

Cardiac Science (NASDAQ:DFIB)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Cardiac Science
Cardiac Science (NASDAQ:DFIB)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Cardiac Science